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Abstract
Background: The treatment of infection-related delayed bone unions is still very challenging for the orthopedic
surgeon. The prevalence of such infection-related types of osteitis is high in complex fractures, particularly in open
fractures with extensive soft-tissue damage. The aim of this study was to develop a new animal model for delayed
union due to osteitis.
Methods: After randomization to infected or non-infected groups 20 Sprague–Dawley rats underwent a transverse
fracture of the midshaft tibia. After intramedullary inoculation with staphylococcus aureus (103 CFU) fracture
stabilization was done by intramedullary titanium K-wires. After 5 weeks all rats were euthanized and underwent
biomechanical testing to evaluate bone consolidation or delayed union, respectively. Micro-CT scans were
additionally used to quantitatively evaluate the callus formation by the score of Lane and Sandhu. Blood samples
were taken to analyze infectious disease markers (day 1, 14 and 35).
Results: Biomechanical testing showed a significant higher maximum torque in the non-infected group 5 weeks
postoperatively compared with the infected group (p < 0.001). According to the Lane and Sandhu score a
significantly higher callus formation was found in the non-infected group (p < 0.001). Similarly, the leucocyte count
in the infected group was significantly higher than in the non-infected group (p < 0.05).
Conclusions: Here we have established a new animal model for delayed osseous union secondary to osteitis. The
animal model appears to be appropriate for future experimental studies to test new therapeutic strategies in these
difficult to treat bone healing complications.
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Background
The treatment of non-healing bone defects, especially
those secondary to infection, is a great challenge for the
orthopaedic surgeon. Treatment often lasts months to
years and involves radical and repeated surgical debride-
ment in combination with intensive antibiotic treatment
[1]. Recurrent infections are not uncommon and can
lead to the loss of the affected extremity, which has
enormous professional, social, financial, and familiar
consequences for patients [1].
The incidence of infections and osteomyelitis after
complex fractures is high, especially in open fractures
with large tissue damage [2, 3]. Staphylococcus aureus
is responsible for approximately 55 % of osteomyelitis
cases [4].
In the last few years, surgeons have begun to use
BMPs in combination with autologous human mesen-
chymal stem cells (MSC) to treat non-unions [5, 6]. The
development of an effective treatment concept could
result in a more confident treatment strategy and ultim-
ately an overall improvement in patients’ quality of life.
In addition, it would decrease the time and costs of
treatment (e.g., a reduction in hospital stay, follow-up
treatment, and resources). The goal of this study was to
develop and establish a new animal model of delayed
fracture healing in order to investigate innovative treat-
ment concepts secondarily.
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Methods
Implant-related infection in rats was induced according
to a previously established protocol [7]. S. aureus was
used for inoculation (subspecies aureus Rosenbach)
obtained from LGC Standards, Wesel, Germany (ATCC
49230). This strain is sensitive to flucloxacillin, genta-
micin, and erythromicin, but resistant to penicillin.
Preparation of bacterial inoculum
For each surgery a new inoculum of S. aureus (ATCC
49230) was prepared by an overnight culture in BD
Brain Heart Infusion (BHI) (Becton Dickinson Diag-
nostic Systems, Heidelberg, Germany) solution. Cells
were pelleted and washed twice in phosphate-buffered
saline (PBS). CFU (colony-forming unit) counts were
determined by plating serial dilutions on blood agar.
The final bacterial suspension in PBS consisted of
103 CFU/10 μl [8].
Implant
Titanium Kirschner wires, 0.8 mm in diameter (Synthes
GmbH, Umkirch, Germany), were used for osteosynthesis.
The following treatment groups were examined:
Group I (infected; n = 10): K-wire osteosynthesis and
infected with 103 CFU Stapylococcus aureus;
Group II (non-infected; n = 10): K-wire osteosynthesis
with no infection;
For biomechanical testing a comparison with the
contralateral tibiae of group I and group II was done
(see Fig. 2).
Animals, operative procedure, and fracture model
All experiments were approved by the Animal Experi-
mentation Ethics Committee of Karlsruhe (35–9185.81/
G-171/11). Twenty female, 6-months-old Sprague–
Dawley rats (Harlan- Winkelmann, Borchen, Germany)
were operated on for study purpose. Surgery was
performed under general anesthesia by weight-
adopted intraperitoneal injection of Xylazin 2 %
(Medistar®; 12 mg/kg body weight) and Ketamanin-
hydrochlorid (Ketavet; 100 mg/ml; 80 mg/kg body
weight) after sedation of the animals with isoflurane
in a sedation-box.
Animals were prepared for surgery as follows:
The right hind leg was shaved, depilated, and disin-
fected with alcohol. The animals were placed on sterile
drapes, the bodies were covered with sterile sheets. Skin
and fascia at the proximal tibial metaphysis were incised
over 5 mm in length. With a k-wire, a 1 mm hole was
drilled through cortical and cancellous bone to access
the medullary cavity at the proximal metaphysis. The
medullary cavity was bluntly reamed with a steel Kirsch-
ner wire (1.0 mm diameter) followed by reaming with a
0.8 mm Kirschner wire in order to reach the narrowing
distal part of the tibial cavity. After removal, 10 μl of
bacterial suspension containing 103 CFU/10 μl of S.
aureus (ATCC 49230) were injected with a 50-μl micro
syringe (Hamilton®, IL, USA) for contamination of the
medullary cavity according to study groups [7].
After contamination, the right tibia and fibula were
fractured with an established fracture device [9]. The
right leg was externally rotated and placed on two
rounded bolts at a 20 mm distance. The leg was fixed on
a stop-plate at a variable distance. A third bolt was
placed 2–4 mm above the tibiofibular junction. A weight
(650 g) was fixed on this bolt with a removable pin. The
drop-down distance of the weight was 15 cm. An
impulse of p = 1.12 Ns generated a closed transverse
fracture of the tibia in the midshaft (AO 42-A3, respect-
ively) and the fibula. After closed reduction, the tibiae
underwent an intramedullary stabilization with a 0.8 mm
titanium Kirschner wire (Synthes GmbH, Umkirch,
Germany). The excess parts of the Kirschner wires were
cut off at the site of entry. Soft tissue was irrigated, and
skin and fascia were sutured in a single knot technique
(Resolon® 3/0 Ethicon, Norderstedt, Germany).
Follow-up
All animals received buprenorphine (0.03 mg/kg bw;
Temgesic®) as analgesic medication perioperatively.
Animals were followed up for 5 weeks and were then
sacrificed. All procedures were carried out under
inhalation anesthesia with isoflurane (Forene®). On the
day of surgery and regularly throughout the observa-
tion period, body weight and body temperature were
measured. The clinical condition of the animals was
evaluated.
μCT scan Evaluation
μCT scans were taken throughout the observation
periods on day 0 and week 5, respectively. μCT scans
were performed with a SkyScan 1076 in vivo x-ray
microtomograph (SkyScan n.v., Aartselaar, Belgium) as
previously described [10]. The tibiae were scanned using
an isotropic voxel size of 19 μm using energy settings of
50 kV and 200 μA, a 0.5-mm aluminum filter, and eight
repeated scans. Image reconstruction was performed
(SkyScan NRecon package v. 1.5.1.4) by correcting for
ring artifacts and beam hardening (20 %). Following
image reconstruction, the individual fracture lines were
identified by simultaneously viewing multiple orthogonal
slices (SkyScan DataViewer v. 1.4). The region of interest
for each bone was determined approximately 3 mm
proximal and distal to the fracture line (150 images).
Bridging of the fracture callus was evaluated by two
independent observers according to the modified x-ray
score of Lane and Sandhu [11]. The ratings for each
sub-item were given according to the degree of bone
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formation and union. In details a completed bone
formation was rated with 4 points, and no bone
formation with 0 points. The degree of bone union
was rated according to the clearance of the fracture
line (4 points = complete clearance with no detectable frac-
ture line, 2 points = partial clearance, and 0 points = no
clearance clearly visible fracture line).
Blood and serum analyses
Blood and serum samples (0.5 mL) were taken from the
cauda vein on days 0, 14, and week 5. The blood samples
were analysed for routine laboratory parameters (blood
count, leucocytes count, and C-reactive protein) as
previously described [9].
Body weight and body temperature
Rectal body temperature was measured and body weight
was determined with a precision scale on days 0, 7, 14,
21 and 28. Further indications for local or systemic
infections were evaluated.
Sacrifice
Under general anesthesia, 3 ml of blood were drawn
from the cauda vein for final blood and serum analyses.
The animals were sacrificed with CO2 in a sedation box.
The right tibiae of the hind legs were dissected under
sterile conditions. The entire soft tissue was removed
from bones.
Microbiological evaluation
The Kirschner wires were explanted, rolled over nutri-
ent agar (BD™ Columbia Agar, Becton Dickinson, Hei-
delberg, Germany), and placed in 2.5 ml sterile TSB.
Agar plates and TSB were incubated at 37.8 °C. After
24 h, CFU on agar plates were counted and bacterial
growth in the tryptic soy solution was evaluated
(cloudy: positive growth; clear: no growth) [12].
Mechanical testing
At 5 weeks after fracture, all animals were killed and
both tibiae were dissected free from soft tissue for
biomechanical torsional testing. After dissection of
the bones, the proximal and distal ends were embed-
ded into two embedding molds with bone cement
(Beracryl, Troller, Fullenbach, Germany). Each embed-
ding mold was connected to a pivoted axis. A linear,
constant feed rate, initiated by a materials testing
machine (Fig. 1) was loaded by a lever attached to
one of the pivoted axes. The bone was preloaded with
an axial force of 5 N and a constant linear propulsion
(v = 2 mm/min) was applied by the testing machine.
The translation of the materials-testing machine was
transformed to a uniform torsional movement. The free
axis was connected with a strain gauge (Fmax = 50 N;
HBM, Germany) that determined the level of torsion and
transferred the data to a calculator.
Statistics
Primary outcome was measured according to the
maximal torque in Nm. Secondary outcome measures
were the modified x-ray score according to Lane and
Sandhu and the leucocyte count. Complete data sets
were available for 20 animals. Mean and standard devi-
ation (SD) were calculated for continuous, median, and
interquartile ranges for ordinal variables. Association
between continuous and discrete variables was tested
with Student’s t test. Data of the outcome variables and
confounders were tested in a one-way analysis. Compari-
son of the data was performed using one-way analysis of
variance (ANOVA) for independent samples and balanced
with the Bonferroni-Holm Test if more than two groups
were compared. In the case of abnormal distribution of
LAR-values in this study, median, interquartile range, and
Mann–Whitney-U test results were calculated. All tests
Fig. 1 Picture of the biomechanical testing machine
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were two-sided and a p value ≤ 0.05 was considered
significant. Statistical analysis was performed using
GraphPad Prism version 4.00 for Windows, GraphPad
Software, San Diego California USA.
Results
Failure parameters
Two animals died due to anesthesia immediately after
operation for reasons that could not be detected. The
dropout animals were replaced.
Mechanical testing
After sacrifice the intramedullary implants were carefully
removed for biomechanical investigation. The K-wires
could be removed easily in all cases, with no differences
detected between the infected and non-infected groups.
The tibiae of group I (infected group) and group II (non-
infected group) were compared with the non-fractured
contralateral tibiae (contralateral side/infected group;
contralateral side /non-infected group; Fig. 2). Maximum
torque (Nm) of the fractured side in the non-infected
group (Group II; n = 10) was significantly higher than the
fractured side in the infected group (Group I; n = 10) after
5 weeks (p < 0.001, ANOVA). In details the tibiae of the
fractured non-infected group II showed an average
maximum torque of 0.081 +/− 0.078 Nm compared to
0.022 +/− 0.041 Nm in the fractured infected group I
(Fig. 2). Maximum torque (Nm) of the fractured side was
significantly lower than the contralateral side in group I
and II (p < 0.001, ANOVA). The differences between
the non-infected and infected group on the non-
fractured contralateral side showed no statistical
significance (p = 0.379; ANOVA).
μCT scan examinations and modified x-ray score accord-
ing to Lane and Sandhu
Compared with the non-infected group (II; n = 10),
the infected group (I; n = 10) showed clearly reduced
consolidation of the fractures after 5 weeks (Fig. 3a
and b). The fracture gap was not bridged after
5 weeks in ten of ten animals. The tibiae of the
non-infected group were bridged completely in nine
of ten animals after 5 weeks (group II). The results
of the modified x-ray score according to Lane and
Sandhu showed highly significant differences between
the two groups. The median score was four (range
2–4) in the non-infected group (II) and 1 (range 0–2)
in the infected group (I) (p < 0.001; Mann–Whitney-U
test) (Fig. 4).
Blood and serum analyses
No significant differences (p > 0.05, ANOVA) for C-reactive
protein were detectable between the infected and
non-infected group and throughout the entire study
period (data not shown). But the leucocyte count
14 days postoperatively showed significant differences
between the two groups. The leucocyte count in the
infected group (n = 10) (11.71 +/− 1.89 × 103 /μl) was
significantly higher than in the non-infected group
(n = 10) (6.25 +/− 4.17 × 103 /μl) (p < 0.05, ANOVA)
(Fig. 5). At the remaining time-points no significant
differences for leucocyte count were found.
Microbiological evaluation / cultures of implants
After sacrifice, Staphylococcus aureus could be cultured
from all implants of group I (infected group; n = 10) fol-
lowing incubation in TSB. The corresponding agar
Fig. 2 Maximum torque (Nm) of the fractured non-infected group II (n = 10) was significantly higher compared to the fractured infected
group I (n = 10) (* p < 0.001, ANOVA). Similarly, statistically significant differences were found between the fractured side of both groups
(infected and non-infected groups) and the contralateral side (* p < 0.001, ANOVA). Asterisk indicates significant difference in comparison
to the other groups; * p < 0.001; mean+/− standard deviation
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plates revealed massive bacterial growth far above
1000 CFU.
All implants of group II (non-infected group; n = 10)
remained sterile in culture.
Body weight and body temperature
No significant differences of body weight and body
temperature were detected between groups. Body weight
moderately decreased in the infected and non-infected
Fig. 3 a X-rays (lateral and axial) of the right tibia of a Sprague–Dawley rat (infected group) 35 days after fracture and intramedullary stabilization
with titanium Kirschner wires. The fracture gap (FG) is still detectable. X-rays of the right tibia clearly depict signs of infection with osteolysis (OL),
periosteal new bone formation (NBF) and sequestered bone (SB). b X-rays (lateral and axial) of the right tibia of a Sprague–Dawley rat (non-infected
group) 35 days after fracture and intramedullary stabilization with titanium Kirschner wires. The progression of consolidation of fracture (COF) in the
non-infected group is clearly recognizable compared to the infected group. No radiographic signs of infection can be observed in animals of the
non-infected group
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group during the first 2 weeks, but the animals gained
weight continuously in the next 3 weeks. Body
temperature remained stable in all groups during the
5 weeks (data not shown).
Discussion
Posttraumatic osteitis along with associated impaired
fracture healing is still a serious complication in ortho-
pedics and trauma surgery. Treatment is difficult and
long lasting. Patients are confronted with substantial and
often irreversible health problems, which have socio-
economic consequences [1, 13]. Especially patients
with open fractures [2, 3] or with extensive soft tissue
damage have a higher risk of infection and therefore
greater chance of impaired healing [14, 15]. Depend-
ing on the patient risk profile, this percentage lies
between 10 and 30 % [1].
Delayed—not due to infection—fracture healing
(hypertrophic non-union) can be successfully treated by
established operative methods for treating non-unions,
e.g., dynamized intramedullary nailing, switching to a
thicker intramedullary nail, autologous cancellous bone
graft, or additional stabilization of the fracture with an
anti-rotation plate [14, 16]. The method of choice for
biological activation of fracture healing with threaten-
ing or manifested atrophic non-union is the application
of autologous cancellous bone grafts [16]. If this
method fails, the treatment of the non-union becomes
problematic [5].
A bacterial infection of the fracture can occur due to
the primary injury, iatrogenic causes during operative
care, or hematogenic factors in the course of therapy
[2, 15, 17–20]. Depending on findings, the removal of
the osteosynthesis material or an extensive debridement
with possible far reaching bone resection may be neces-
sary [2]. The optimal treatment for non-union and
delayed union secondary to osteitis involves both
surgery and medical treatment [21, 22]. A radical
surgical debridement in combination with stable osteo-
synthesis should be followed by an extended period of
appropriate antibiotic treatment.
S. aureus is one of the most common bacterial
pathogens in orthopedic and traumatological infections
after open fractures. Furthermore, animal model experi-
ments in the literature have been conducted mainly with
S. aureus [7, 23]. For this reason, we have chosen this
pathogen in our newly developed animal model of delayed
osseous union secondary to osteitis.
In this study, we have developed a new animal model
for delayed osseous union secondary to osteitis through
the use of both μCT scan examinations and biomechan-
ical investigations. To our knowledge this is the first
animal model of delayed osseous union secondary to
osteitis that closely monitors the course of delayed
osseous union according to biomechanical investigations
and μCT scan examinations. Together with the previ-
ously shown biomechanical testing [8] and the μCT scan
examinations, this model will be appropriate for future
studies assessing the efficacy of new osteosynthesis
techniques with bone substitutes and growth factors
aimed at accelerating bone healing. In addition, it appears
to be valuable for future experimental studies testing new
therapeutic strategies for delayed osseous union [24].
Many alternative models with both their advantages and
disadvantages have been described in the literature. Models
of impaired fracture healing can be divided into models of
delayed union or nonunion (atrophic and hypertrophic),
segmental defects, and fracture-related osteitis [25].
Many different bone defect animal models of osteitis
have been described in the literature [26–29]. Windolf et
al. [27, 28] used a mice model with locking plate fracture
Fig. 4 Outcome of the modified x-ray score of Lane and Sandhu
35 days post op. X-ray score of Lane and Sandhu in the non-infected
group (n = 10) (median = 4) is significantly higher than in the infected
group (n = 10) (median = 1); * p < 0.001
Fig. 5 Results of blood analyses 2 weeks post op. A significantly
higher leucocyte count is seen in the infected group (n = 10)
(11.71 +/− 1.89 × 103 /μl) compared to the non-infected group (n = 10)
(6.25 +/− 4.17 × 103 /μl); * p < 0.05; mean+/− standard deviation
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stabilization, and here bone healing was evaluated by
radiological, immunological and histological evaluation.
Schindeler et al. [29] established a rat open fracture model
by inoculation with Staphylococcus aureus. In this study
the antibiotic CSA-90 was tested alone and in combin-
ation with recombinant human bone morphogenetic
protein 2 (rhBMP 2), respectively. An open femoral
osteotomy with periosteal stripping was performed to
generate an open fracture. Radiographic analysis using a
μCT and histological examination were used to evaluate
the amount of new bone formation. Chen et al. [26] used
a rat femur model with a segmental bone defect by
creating a chronic infection with stabilization by a plate
and k-wires. The bone healing was assessed by μCT, histo-
logical evaluation and torsional failure testing. In all these
animal models fracture was created using an osteotomy
[26–29]. In the current study we have introduced a model
in which the tibiaewere fractured with an established frac-
ture device [30], which might allow an appropriate simula-
tion of a “typical” closed fracture. In opposite to an
osteotomy model the soft tissue remained closed in our
model. However own pre-experiments showed that with
our fracture device the individual fracture pattern was
more complex and difficult to predict. Consequently we
carefully aimed to create the fracture as standardized as
possible to obtain a transverse fracture type (42-A3/AO).
On the other hand one disadvantage of our model could
be the relatively poor reproducibility as compared to an
osteotomy model, which might explain a poorer healing
tendency of fracture models [24]. Furthermore, only one
other study has evaluated the bone healing using a
torsional failure testing [26], despite the fact that a
biomechanical stability testing is probably one of the most
important parameters to evaluate bone healing in compli-
cated fracture healing [24].
Despite the growing knowledge on the mechanisms
of fracture healing, delayed healing and non-union
formation remain major clinical challenges. Animal
models are needed to study the complex process of
normal and impaired fracture healing and to develop
new therapeutic strategies [24].
Conclusions
A new animal model for delayed osseous union second-
ary to osteitis has been developed. Such standardized
animal models are essential for future experimental
studies to evaluate new therapeutic strategies in these
difficult to treat bone healing complications.
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